Markets:

Overview

News

Currencies

International

Treasuries

Kodiak Sciences Inc - Common Stock (NQ:KOD)

100.40 +3.36 (+3.46%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kodiak Sciences Inc - Common Stock

< Previous 1 2 3 4 5 6 Next >

Kodiak Sciences’ Two Wet AMD Treatments Match Aflibercept in Phase III Study ↗

October 02, 2026

Kodiak Sciences (NASDAQ:KOD) reported that its Phase III DAYBREAK study met primary endpoints for two investigational treatments in treatment-naïve patients with wet age-related macular degeneration,...

Via MarketBeat

Why Kodiak Sciences Skyrocketed Today ↗

September 28, 2026

The biotech is developing innovative therapies for people with eye diseases.

Via The Motley Fool

These stocks are moving in today's pre-market session ↗

September 28, 2026

Via Chartmill

3 Small-Cap Biotechs With Binary Catalysts on the Calendar ↗

September 13, 2026

Kodiak Sciences, Capricor Therapeutics and Invivyd each face pivotal clinical trial or FDA decisions before the end of 2026 that could significantly move their stock prices.

Via MarketBeat

Kodiak CFO Sells $1 Million in Stock as Shares Surge 650%. What Investors Should Know ↗

June 09, 2026

This clinical-stage biotech focused on retinal therapies reported a notable insider sale amid a year of exceptional stock performance.

Via The Motley Fool

Topics Regulatory Compliance

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.

Via The Motley Fool

Topics Regulatory Compliance

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through late-stage trials.

Via The Motley Fool

Topics Regulatory Compliance

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.

Via The Motley Fool

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

March 31, 2026

Via Chartmill

Which stocks are gapping on Friday? ↗

March 27, 2026

Via Chartmill

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action? ↗

March 27, 2026

Kodiak Sciences Inc (NASDAQ: KOD) shares are trading higher Friday after positive Phase 3 GLOW2 results for Zenkuda in diabetic retinopathy.

Via Benzinga

Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗

March 26, 2026

Via Chartmill

Here are the top movers in Thursday's session. ↗

March 26, 2026

Via Chartmill

Thursday's session: gap up and gap down stocks ↗

March 26, 2026

Via Chartmill

Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment

March 26, 2026

On March 26, 2026, Kodiak Sciences (Nasdaq: KOD) saw its shares ignite, surging 19% in heavy trading following the announcement of overwhelmingly positive topline results from its Phase 3 GLOW2 study....

Via MarketMinute

These stocks that are showing activity before the opening bell on Thursday. ↗

March 26, 2026

Via Chartmill

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused pipeline in ophthalmology.

Via The Motley Fool

Topics Regulatory Compliance

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

This clinical-stage biotech develops precision oncology therapies and diagnostics targeting unmet needs in breast and ovarian cancer.

Via The Motley Fool

Topics Regulatory Compliance

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

This clinical-stage biotech develops small-molecule therapies for liver and metabolic diseases, targeting unmet needs in NASH and obesity.

Via The Motley Fool

Topics Regulatory Compliance

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

This clinical-stage biotech develops targeted cancer therapies, leveraging strategic partnerships and a differentiated oncology pipeline.

Via The Motley Fool

Topics Regulatory Compliance

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy ↗

February 23, 2026

Focused on retinal disease therapeutics, this clinical-stage biotech advances drug candidates for vision-threatening conditions.

Via The Motley Fool

Topics Regulatory Compliance

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗

February 19, 2026

Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology.

Via The Motley Fool

Topics Regulatory Compliance

These stocks are gapping in today's session ↗

December 17, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

This Coinbase Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday ↗

October 24, 2025

Via Benzinga

Gapping stocks in Monday's session ↗

October 20, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗

October 20, 2025

Via Benzinga

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday ↗

September 25, 2025

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Top stock movements in today's session. ↗

September 22, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 22, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.